Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 20Prostatic Neoplasms 11Neoplasm Metastasis 9Melanoma 8Lung Neoplasms 8Carcinoma, Renal Cell 8Carcinoma, Non-Small-Cell Lung 8Carcinoma, Hepatocellular 8Kidney Neoplasms 7Sarcoma 6Liver Neoplasms 6Triple Negative Breast Neoplasms 3Thyroid Neoplasms 3Small Cell Lung Carcinoma 3Osteosarcoma 3Desmoid Tumors 3Carcinoma, Ductal, Breast 3Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Tongue Neoplasms 2Pain 2Keratosis, Actinic 2Esophageal Neoplasms 2Disease 2Cholangiocarcinoma 2Carcinoma, Transitional Cell 2Carcinoma, Intraductal, Noninfiltrating 2Breast Neoplasms, Male 2Wilms Tumor 1Uveal Melanoma 1

Interventions

Electroporation 1Cryosurgery 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Advanced Intestinal Cancer × Cryosurgery × Clear all
NCT03350490 2019-01-25

Bioinformation Therapy for Intestinal Cancer

Fuda Cancer Hospital, Guangzhou

Phase 2/3 Completed
120 enrolled

Advanced Intestinal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡